India’s MedTech and healthtech startup ecosystem has quietly become one of the country’s largest and most consequential startup categories — over 14,000 healthtech startups by recent count, with roughly 30% of healthtech venture capital now flowing specifically into MedTech and diagnostics rather than pure telemedicine, according to Bain & Company’s analysis of 2024–2025 funding patterns. That’s a meaningful shift: India’s first healthtech wave was largely about digitising access (teleconsultation, e-pharmacy); the current wave is about building the actual devices, diagnostics, and clinical infrastructure underneath.
Here are 15 companies across robotics, diagnostics, implants, remote monitoring, and digital health infrastructure genuinely worth watching through 2026–27, organised by segment. We’ll refresh this list quarterly as the sector moves fast.
Surgical Robotics & Devices
1. SS Innovations International (SSi Mantra) — India’s own surgical robotics platform, and currently the only one CDSCO-approved for telesurgery in the country. By Q2 2026, the company had placed 224 systems across 12 countries, with quarterly revenue of $13.9 million, up 39% year-over-year. Its telesurgery milestones — including an 18-procedure marathon across Indian cities in a single day and a 22,000 km telesurgery link to Colombia — make it one of the most technically ambitious Indian MedTech companies operating today.
2. Gravity Medical Technology (Supernova stent retriever) — Developer of the Supernova stent retriever, the first stroke thrombectomy device in India approved by CDSCO based entirely on domestic clinical trial data (the GRASSROOT trial, run through AIIMS Delhi). Scheduled for commercial launch in India in February 2026, it’s a genuine first for Indian neurovascular MedTech.
3. Meril Life Sciences — The Vapi, Gujarat-headquartered device major behind the Mizzo Endo 4000 soft-tissue surgical robot and the MISSO orthopaedic knee-surgery robot, the latter priced at roughly ₹2 crore against da Vinci’s ₹6 crore-plus — an explicit affordability play aimed at Tier-2 and Tier-3 hospitals, with a stated ambition to scale to 1,000 installations within three years.
4. Perfint Healthcare — A Chennai-based medical robotics company building image-guided intervention systems for oncology, including robotic-assisted biopsy and ablation platforms used in cancer diagnosis and treatment — a less publicised but clinically important corner of India’s robotics ecosystem, focused on precision intervention rather than open surgery.
AI Diagnostics & Imaging
5. Qure.ai — India’s most internationally validated AI diagnostics company, best known for qXR, its chest X-ray AI tool for tuberculosis and lung abnormality screening. Deployed across more than 2,600 sites in 67-plus countries, with independent health-economics data (an IIPH Gandhinagar HTA and an ICMR cost-effectiveness assessment) showing it both improves detection rates and reduces per-case cost — a rare combination of scale and independently verified impact in Indian AI health-tech.
6. Niramai — Bengaluru-based, founded in 2016 by Geetha Manjunath and Nidhi Mathur, Niramai has built Thermalytix, a radiation-free breast cancer screening tool using high-resolution thermal imaging and AI analytics. Its pitch is specifically about reaching women underserved by traditional mammography — younger women, and those in areas without easy access to radiology infrastructure — through a portable, privacy-preserving screening approach. The company has raised over $8.6 million from investors including pi Ventures, Ankur Capital, and 500 Global.
7. SigTuple — Also Bengaluru-based, SigTuple has built AI-powered smart microscopes and cloud-based analytics that automate interpretation of blood, urine, and pathology slides — a labour-intensive diagnostic bottleneck in Indian pathology labs that AI-assisted image analysis is well suited to address. The company has raised around $30 million from investors including Accel and Chiratae Ventures.
8. Tricog Health — A cardiac diagnostics company that built its reputation on rapid, AI-assisted ECG interpretation and remote cardiac diagnostics support for hospitals and clinics that lack an on-site cardiologist — part of the same “specialist expertise, delivered remotely” pattern showing up across Indian MedTech, from Tele-ICU to teleradiology.
Remote Monitoring & Hospital-at-Home
9. Dozee — A contactless remote patient monitoring platform using under-mattress sensor technology that captures micro-vibrations from the body to continuously track heart rate, respiration, and sleep patterns without any wearable device. Dozee has raised roughly $42 million across 15 funding rounds, secured a CE Mark in mid-2025 to unlock international markets, and has been deployed in hospital “smart ward” and AI command centre partnerships with institutions including Sahyadri Hospitals and Sancheti Hospital — a genuinely scaled example of India-built hospital-to-home monitoring infrastructure.
10. Cloudphysician — A cloud-based critical care technology company powering Tele-ICU deployments across India, connecting intensivist expertise at central hubs to ICU beds in hospitals that lack round-the-clock critical care staffing — addressing exactly the specialist-shortage gap that makes Tele-ICU one of India’s more operationally mature remote-care models.
11. NemoCare — A neonatal and maternal health-tech company building deep-tech monitoring solutions specifically for newborn and pregnancy care — a segment that has attracted particularly strong investor interest given how acute India’s neonatal mortality and maternal health challenges remain outside major urban centres.
Cell & Gene Therapy, Genomics
12. ImmunoACT — Incubated at IIT Bombay in partnership with Tata Memorial Centre, ImmunoACT developed NexCAR19, India’s first indigenous CAR-T cell therapy, priced at roughly $30,000 — around 13 times cheaper than comparable US-approved CAR-T products. A January 2026 partnership with Cipla is now taking the therapy into South Africa, Algeria, and Morocco, making it one of the clearest examples of an Indian MedTech innovation scaling into an export platform.
13. MedGenome — A genomics and diagnostics company offering advanced genetic testing for rare diseases, cancer, and inherited conditions — increasingly relevant infrastructure as India builds out its National Policy for Rare Diseases and precision oncology ambitions, both areas where genomic diagnostic capacity is currently a binding constraint.
Consumer Health & Wearables
14. Ultrahuman — India’s most visible consumer CGM and wearables brand, built around the Ultrahuman M1 metabolic tracking platform and its Ring AIR wearable line. It’s worth noting honestly: Ultrahuman’s core innovation is its software and metabolic-scoring layer rather than proprietary sensor manufacturing — its CGM platform runs on third-party sensors (historically Abbott’s FreeStyle Libre, more recently GlucoRx’s Vixxa 2) — but it has done more than any Indian company to popularise continuous health monitoring as a mainstream consumer category.
15. Innovaccer — A healthcare data platform company (now valued as one of India-origin healthtech’s unicorns) building population health management and clinical data infrastructure for hospital systems, primarily serving the US market but built substantially by Indian engineering talent — representative of a growing category of India-headquartered or India-engineered health-data infrastructure companies serving global, not just domestic, health systems.
What’s Driving This Cohort
A few patterns stand out across this list that are worth watching as indicators of where the next wave of Indian MedTech investment is heading. IIT Bombay’s ATMAN 3.0 deep-tech accelerator funded six health startups in January 2026 from a pool of 173 applicants — a 3.5% acceptance rate — and deliberately selected for diagnostics, robotics, AI monitoring, and surgical guidance companies over the software-only telemedicine platforms that dominated India’s first healthtech funding wave. That selection bias mirrors the broader capital shift Bain has tracked: money is moving toward companies building genuine clinical hardware and diagnostic infrastructure, not just consumer-facing access layers.
It’s also worth being honest about where genuine “deep manufacturing” ends and “assembly or software layer” begins across this list — a distinction that matters more in Indian MedTech than in most tech sectors, given the PLI scheme’s own explicit acknowledgment that a lot of what gets called “Made in India” is still closer to final-stage assembly. Companies like SS Innovations, Gravity Medical, and ImmunoACT are building genuine core IP and manufacturing capability; others, like Ultrahuman, are building excellent software and go-to-market layers on top of imported or licensed hardware. Both are valuable, but they’re different kinds of company, and worth evaluating accordingly.
The Bottom Line
India’s MedTech startup list is no longer dominated by e-pharmacy and teleconsultation apps the way it was five years ago — it’s genuinely diversifying into surgical robotics, AI diagnostics with independently verified clinical impact, cell and gene therapy manufacturing, and remote monitoring hardware built for Indian hospital infrastructure specifically. This list will keep shifting fast; check back for quarterly updates as funding rounds, CDSCO approvals, and international expansion deals reshape who’s actually leading each category.
References
- Inc42 — Top 30 Healthtech Startups In India 2026 By Funding (https://inc42.com/lists/30-healthtech-startups-by-funding/)
- GrowthJockey — Top 20 Healthcare Startups In India: AI & HealthTech Companies (https://www.growthjockey.com/blogs/healthcare-startups-in-india)
- Inventiva — Top 10 HealthTech Startups In 2026 (https://www.inventiva.co.in/trends/top-10-healthtech-startups-in-2026/)
- Tracxn — Dozee Company Profile (https://tracxn.com/d/companies/dozee/)
- Tracxn — Niramai Company Profile (https://tracxn.com/d/companies/niramai/)
- PitchBook — Niramai Company Profile: Valuation, Funding & Investors (https://pitchbook.com/profiles/company/180170-65)
- Inventiva — Top 10 Best MedTech Companies In India 2025 (https://www.inventiva.co.in/trends/medtech-companies-india-2025/)
- Medical Startups — Top 100 Medical and Healthcare Startups in India 2026 (https://www.medicalstartups.org/country/India/)
- HealthBuzz — Top 10 HealthTech Startups Reshaping Indian Healthcare in 2026 (https://healthbuzz.in/top-10-healthtech-startups-reshaping-indian-healthcare-in-2026/)
- ImmunoACT — Official Website (https://immunoact.com/)
Note: Funding figures, employee counts, and valuations reflect the most recently available data as of the publish date and change frequently; verify current figures directly with each company or through updated Tracxn/PitchBook data before citing in investment or partnership contexts. This list reflects editorial selection based on public funding, deployment, and regulatory milestones, not a ranked or exhaustive index of the sector.